440 related articles for article (PubMed ID: 20381465)
1. Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist apomorphine.
Freo U; Merico A; Ermani M; Ori C
Brain Res; 2010 Jun; 1335():24-34. PubMed ID: 20381465
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin.
Freo U; Holloway HW; Greig NH; Soncrant TT
Psychopharmacology (Berl); 1992; 107(1):30-8. PubMed ID: 1534179
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
[TBL] [Abstract][Full Text] [Related]
4. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
Kitamura Y; Kitagawa K; Fujitani Y; Shibata K; Araki H; Sendou T; Gomita Y
Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
[TBL] [Abstract][Full Text] [Related]
5. Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
de Bortoli VC; Nogueira RL; Zangrossi H
Psychopharmacology (Berl); 2006 Jan; 183(4):422-8. PubMed ID: 16258751
[TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats.
Freo U; Pietrini P; Pizzolato G; Furey-Kurkjian M; Merico A; Ruggero S; Dam M; Battistin L
Brain Res; 1995 Apr; 677(2):213-20. PubMed ID: 7552245
[TBL] [Abstract][Full Text] [Related]
7. Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans.
Baumann MH; Rothman RB
Biol Psychiatry; 1998 Oct; 44(7):578-91. PubMed ID: 9787882
[TBL] [Abstract][Full Text] [Related]
8. Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.
Carrasco GA; Van de Kar LD; Jia C; Xu H; Chen Z; Chadda R; Garcia F; Muma NA; Battaglia G
J Pharmacol Exp Ther; 2007 Mar; 320(3):1078-86. PubMed ID: 17159160
[TBL] [Abstract][Full Text] [Related]
9. Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT).
Fox MA; Stein AR; French HT; Murphy DL
Br J Pharmacol; 2010 Feb; 159(4):879-87. PubMed ID: 20128812
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
Kleven MS; Assié MB; Koek W
J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
[TBL] [Abstract][Full Text] [Related]
12. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
De Vry J; Schreiber R; Melon C; Dalmus M; Jentzsch KR
Eur Neuropsychopharmacol; 2004 Dec; 14(6):487-95. PubMed ID: 15589388
[TBL] [Abstract][Full Text] [Related]
13. Limited participation of 5-HT(1A) and 5-HT(2A/2C) receptors in the clozapine-induced Fos-protein expression in rat forebrain regions.
Sebens JB; Kuipers SD; Koch T; Ter Horst GJ; Korf J
Eur J Pharmacol; 2000 Nov; 408(1):11-7. PubMed ID: 11070178
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of 5-HT1A receptors by 5-HT2A receptors in neuroendocrine neurons in vivo.
Zhang Y; Gray TS; D'Souza DN; Carrasco GA; Damjanoska KJ; Dudas B; Garcia F; Zainelli GM; Sullivan Hanley NR; Battaglia G; Muma NA; Van de Kar LD
J Pharmacol Exp Ther; 2004 Jul; 310(1):59-66. PubMed ID: 15064330
[TBL] [Abstract][Full Text] [Related]
15. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
Gogos A; Kwek P; Chavez C; van den Buuse M
J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
[TBL] [Abstract][Full Text] [Related]
16. HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems.
Fujiwara T; Snada M; Kofuji T; Yoshikawa T; Akagawa K
Eur J Neurosci; 2010 Jul; 32(1):99-107. PubMed ID: 20576034
[TBL] [Abstract][Full Text] [Related]
17. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
18. Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine.
Berendsen HH; Broekkamp CL
Psychopharmacology (Berl); 1997 Oct; 133(3):275-82. PubMed ID: 9361334
[TBL] [Abstract][Full Text] [Related]
19. CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors.
Mato S; Aso E; Castro E; Martín M; Valverde O; Maldonado R; Pazos A
J Neurochem; 2007 Dec; 103(5):2111-20. PubMed ID: 17944876
[TBL] [Abstract][Full Text] [Related]
20. A chronic treatment with fluoxetine decreases 5-HT(1A) receptors labeling in mice selected as a genetic model of helplessness.
Naudon L; El Yacoubi M; Vaugeois JM; Leroux-Nicollet I; Costentin J
Brain Res; 2002 May; 936(1-2):68-75. PubMed ID: 11988231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
